Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Genome Biology|June 19, 2024
An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programsRichard H Chapple, Xueying Liu, Sivaraman Natarajan, et al.Biorxiv : the Preprint Server for Biology|May 7, 2024
An integrated single-cell RNA-seq map of human neuroblastoma tumors and preclinical models uncovers divergent mesenchymal-like gene expression programsRichard H Chapple, Xueying Liu, Sivaraman Natarajan, et al.Nature Communications|February 28, 2025
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acidMin Pan, Yinwen Zhang, William C Wright, et al.Biorxiv : the Preprint Server for Biology|May 27, 2024
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acidMin Pan, Yinwen Zhang, William C Wright, et al.Blood|August 14, 2025
Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemiaLindsey E Montefiori, Ilaria Iacobucci, Qingsong Gao, et al.Nature Communications|November 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, William C Wright, Richard H Chapple, et al.Nature Communications|February 13, 2023
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemiaJennifer L Kamens, Stephanie Nance, Cary Koss, et al.Blood|March 6, 2026
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemiaDanika Di Giacomo, Petri Pölönen, Valentina Bardelli, et al.Nature Microbiology|October 31, 2025
Prodrug florfenicol amine is activated by intrinsic resistance to target Mycobacterium abscessusGregory A Phelps, Sinem Kurt, Alexander R Jenner, et al.Pageof 3